Objective demonstration of cervical softening with a prostaglandin F2αgel during first trimester abortion
- 1 June 1982
- journal article
- research article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 20 (3) , 195-199
- https://doi.org/10.1016/0020-7292(82)90071-6
Abstract
In a prospective study the cervix-softening and dilating effects of intracervically applied prostaglandin F2.alpha. gel were investigated in 100 patients during induced abortion in the 7-12th wk of pregnancy. A specially designed tonometer was used to measure the resistance of the cervical canal before as well as 6-8 h, 4 days and 5-6 wk after gel application. The cervix of 99 patients was freely passable without use of undue force for at least Hegar 8 after treatment. Measurements in 96 patients 5-6 wk after the operation showed good general agreement with those values obtained before gel application. No spontaneous or operation-induced lesions of the cervix occurred. Intracervical prostaglandin gel application is a safe, practicable and gentle method for avoiding dilation-induced complications during 1st trimester abortions.Keywords
This publication has 6 references indexed in Scilit:
- Wirksamkeit und Nebenwirkungen der intrazervikalen Prostaglandin F2-Alpha-Gel-Applikation im 1. Trimenon*Geburtshilfe und Frauenheilkunde, 1980
- RIPENING OF THE CERVIX BY INTRACERVICAL APPLICATION OF PGE2‐GEL BEFORE TERMINATION OF PREGNANCY WITH DILATATIONU AND EVACUATIONActa Obstetricia et Gynecologica Scandinavica, 1979
- Reduction of cervical resistance by prostaglandin suppositories prior to dilatation for induced abortionAmerican Journal of Obstetrics and Gynecology, 1975
- A new electronic force monitor to measure factors influencing cervical dilation for vacuum curettageAmerican Journal of Obstetrics and Gynecology, 1974
- Administration of 15-methyl-prostaglandin F2α as a pre-operative means of cervical dilatationProstaglandins, 1973
- THERAPEUTIC ABORTION USING PROSTAGLANDIN F2αThe Lancet, 1970